Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor

Neuromuscular Disorders

Volumn 18, Issue 8, 2008, Pages 678-680

  Maggi, Lorenzo ^a   Andreetta, Francesca ^a   Antozzi, Carlo ^a   Confalonieri, Paolo ^a   Cornelio, Ferdinando ^a   Scaioli, Vidmer ^a   Mantegazza, Renato ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Myasthenia gravis; Ryanodine receptor antibodies; Seronegative myasthenia; Thymoma; Titin antibodies

Indexed keywords

ANTIBODY; AZATHIOPRINE; CHOLINERGIC RECEPTOR; CHOLINESTERASE INHIBITOR; MUSCLE SPECIFIC KINASE ANTIBODY; PREDNISONE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; ELECTROMYOGRAM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MONOTHERAPY; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RECURRENT DISEASE; THYMECTOMY; THYMOMA; TREATMENT FAILURE; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; THYMOMA; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48549100777     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.06.368     Document Type: Article

References (10)

1. Vincent A., Bowen J., Newsom-Davis J., and McCoville J. Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol 2 (2003) 99-106
2. Budde J.M., Morris C.D., Gal A.A., Mansour K.A., and Miller Jr. J.I. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg 72 (2001) 197-202
3. Evoli A., Minisci C., Di Schino C., et al. Thymoma in patients with MG: characteristics and long-term outcome. Neurology 59 (2002) 1844-1850
4. Oger J.J. Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis. Ann NY Acad Sci 681 (1993) 110-112
5. Rosai J., and Sobin L.H. Histological typing of tumors of the thymus. World health organization, international histological classification of tumors. 2nd ed. (1999), Springer, New York 9-14
6. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow-up study of thymoma with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
7. Saka E., Topcuoglu M.A., Akkaya B., Galati A., Onal M.Z., and Vincent A. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 65 (2005) 782-783
8. Deymeer F., Gungor-Tuncer O., Yilmaz V., et al. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 68 (2007) 609-611
9. Lauriola L., Raneletti F., Maggiano N., et al. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64 (2005) 536-538
10. Romi F., Gilhus N.E., Varhaug J.E., Myking A., and Aarli J.A. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. Eur J Neurol 10 (2003) 701-706